Investment Managers Series Trust II - Tradr 2X Long CBRS Daily ETF
CBRX
Chicago Board Options Exchange- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 181 Westchester Avenue, Suite 402 Port Chester NY United States of America 10573
- IPO Date
- May 29, 2026
- Website
- tradretfs.com
- Similar Companies
- Business
- Tradr 2X Long CBRS Daily ETF is a U.S.-domiciled leveraged exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to 200% of the daily performance of the common shares of Cerebras Systems Inc. (Nasdaq: CBRS). The fund is sponsored by Investment Managers Series Trust II and managed by AXS Investments LLC under the Tradr ETFs brand. It provides investors with a single-stock, daily-reset leveraged exposure product designed for tactical trading rather than for achieving its stated objective over periods longer than one trading day. The fund maintains at least 80% exposure to financial instruments providing two-times leveraged exposure to CBRS and may employ derivatives, including swaps and options, as well as direct equity positions and other instruments to obtain its targeted exposure. Its principal product is shares of the Tradr 2X Long CBRS Daily ETF, listed on NYSE Arca under the ticker CBRX; the fund focuses on the U.S. public-equity market and is economically linked to Cerebras Systems, an artificial-intelligence and semiconductor technology company. Formed and launched on May 28, 2026, with first trading reported on May 29, 2026, CBRX represents a recent expansion of the Tradr/AXS leveraged single-stock ETF lineup and was introduced to provide 2x daily long exposure to CBRS. The fund is domiciled in the United States and carries a reported net expense ratio of 1.49%.